Middle East & Africa Rapid Test Kit Market to 2030 - By Size, Share, Growth by End User and Forecast

Name: Middle East & Africa Rapid Test Kit Market
SKU: Life Sciences
Rating: 4.9 (15 reviews)

The Middle East & Africa rapid test kit market was valued at US$ 849.64 million in 2022 and is expected to reach US$ 1,174.76 million by 2030; it is estimated to record a CAGR of 4.1% from 2022 to 2030.

Innovations in Rapid Antigen Tests Boost Middle East & Africa Rapid Test Kit Market

Operations of multiplex rapid antigen tests are based on multicolored nanoparticles and cross-reactive antibodies, and these test kits can be developed at low costs. When various respiratory pathogens are circulating simultaneously in a host body, rapid multiplex diagnostic testing helps healthcare providers supervise their patients with greater effectiveness. These tests can help avoid misdiagnosis that is possible due to overlapping clinical symptoms. By eliminating diagnostic uncertainty, they help healthcare providers make apt decisions about the commencement and discontinuation of antimicrobial therapies. Compared to single specimen antigen tests kits, multiplex rapid antigen tests kits can detect many respiratory viruses from a single specimen, without compromising on the quality of results. Thus, innovations such as multiplex rapid antigen tests are emerging as future trends in the rapid test kits market.

Middle East & Africa Rapid Test Kit Market Overview

The Saudi Arabia rapid test kits market is growing at a fast pace, driven by a huge population base and the increase in the prevalence of infectious diseases. According to WHO, influenza and pneumonia deaths reached 4.58% of total deaths in the country. To address the growing number of influenza cases, the Public Health Laboratory in Saudi Arabia fulfilled all the requirements by WHO to be recognized as a national influenza center for Saudi Arabia. According to Gulf News, 3,367 people were infected with malaria in Saudi Arabia in 2020.

According to the International Diabetes Federation (IDF), in Saudi Arabia, the total cases of diabetes in adults was 4.27 million in 2021. Thus, the growing cases of diabetes is anticipated to propel the growth of the rapid test kits market in the country.

Middle East & Africa Rapid Test Kit Market Revenue and Forecast to 2030 (US$ Million)

Get more information on this report

Middle East & Africa Rapid Test Kit Strategic Insights

Strategic insights for the Middle East & Africa Rapid Test Kit provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

strategic-framework/middle-east-and-africa-rapid-test-kit-market-strategic-framework.webp

Get more information on this report

Middle East & Africa Rapid Test Kit Report Scope

Report Attribute	Details
Market size in 2022	US$ 849.64 Million
Market Size by 2030	US$ 1,174.76 Million
Global CAGR (2022 - 2030)	4.1%
Historical Data	2020-2021
Forecast period	2023-2030
Segments Covered	By Type Rapid Antigen Testing Rapid Antibody Testing By Product Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit By Application Blood Glucose Testing Infectious Disease Testing Pregnancy and Fertility Cardiometabolic Testing
Regions and Countries Covered	Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	F. Hoffmann-La Roche Ltd Becton Dickinson and Co ARKRAY Inc Fujirebio Europe NV bioMerieux SA Cepheid Meril Life Sciences Pvt Ltd QIAGEN NV Guangzhou Wondfo Biotech Co Ltd Abbott Laboratories

Get more information on this report

Middle East & Africa Rapid Test Kit Regional Insights

The geographic scope of the Middle East & Africa Rapid Test Kit refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

geography/middle-east-and-africa-rapid-test-kit-market-geography.webp

Get more information on this report

Middle East & Africa Rapid Test Kit Market Segmentation

The Middle East & Africa rapid test kit market is segmented based on type, product, technology, application, end user, and country. Based on type, the Middle East & Africa rapid test kit market is segmented into rapid antigen testing, rapid antibody testing, and others. The rapid antigen testing segment held the largest market share in 2022.

In terms of product, the Middle East & Africa rapid test kit market is bifurcated into over-the-counter rapid testing kit and professional rapid testing kit. The over-the-counter rapid testing kit segment held a larger market share in 2022.

By technology, the Middle East & Africa rapid test kit market is segmented into lateral flow assay, solid phase, agglutination, immunospot assay, and cellular component-based. The lateral flow assay segment held the largest market share in 2022.

Based on application, the Middle East & Africa rapid test kit market is categorized into blood glucose testing, infectious disease testing, pregnancy and fertility, cardiometabolic testing, and others. The blood glucose testing segment held the largest market share in 2022.

In terms of end user, the Middle East & Africa rapid test kit market is segmented into hospital and clinics, home care, diagnostics centers, and others. The hospital and clinics segment held the largest market share in 2022.

Based on country, the Middle East & Africa rapid test kit market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa rapid test kit market share in 2022.

F. Hoffmann-La Roche Ltd, Becton Dickinson and Co, ARKRAY Inc, Fujirebio Europe NV, bioMerieux SA, Cepheid, Meril Life Sciences Pvt Ltd, QIAGEN NV, Guangzhou Wondfo Biotech Co Ltd, Abbott Laboratoriess, Premier Medical Corp Pvt Ltd, Bio-Rad Laboratories Inc, Hologic Inc, DiaSorin SpA, and Beckman Coulter Inc are some of the leading players operating in the Middle East & Africa rapid test kit market.

Identical Market Reports with other Region/Countries